Company:  BIOPHARMX CORP (BPMX)
Form Type:  DEF 14A
Filing Date:  6/5/2017 
CIK:  0001504167 
Address:  1505 ADAMS DRIVE, SUITE D 
City, State, Zip:  MENLO PARK, California 94025 
Telephone:  650-889-5020 
Fiscal Year:  01/31 
Last Trade
Last Trade: 
$0.12  
Change: 
-0.0633 (-34.05%)  
Trade Time: 
03:46 PM EST  
Market Cap: 
$9.80M
Trade BPMX now with 

© 2017  
Description of Business
We are a specialty pharmaceutical company focused on utilizing our proprietary drug delivery technologies to develop and commercialize novel prescription products that address large markets in dermatology. Our objective is to develop products that treat health or age­related conditions that: (1) are not presently being addressed or treated or (2) are currently treated with drug therapies or drug delivery approaches that are sub­optimal.
Register and access this filing in:     
  FORM DEF 14A
    NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
    PROXY STATEMENT FOR 2017 ANNUAL MEETING OF STOCKHOLDERS
    Compensation Committee Interlocks and Insider Participation
    PROPOSAL NO. 1
      NAME AND TITLE
    Director Compensation Fiscal Year 2017
    PROPOSAL NO. 2
    PROPOSAL NO. 3
    ADVISORY VOTE ON EXECUTIVE COMPENSATION
    SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
      BENEFICIAL OWNERS
      COMPENSATION TABLE
    REPORT OF THE AUDIT COMMITTEE
    Stockholder Proposals to be Presented at Next Annual Meeting
    OTHER MATTERS